U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

LILIUM LANCIFOLIUM WHOLE

MORE DETAILS

079XQO23D9

structurally diverse
Status:
Possibly Marketed Outside US
Source:
Deluqing by Shenzhen Deyintang Biotechnology Co., Ltd.
(2022)
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d89570ad-0e02-1c54-e053-2a95a90a34dc
First approved in 2012
Source:
DR. IASO by IASO Inc
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f6357c9e-f50a-425d-a7b1-a9a9be0b436e
Class:
STRUCTURALLY DIVERSE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966